Available Assets
The innovative and sustainable project portfolio of Helmholtz Zentrum München currently comprises several innovative assets for the development of therapeutics, diagnostics and medical devices covering a significant range of diseases and indications. For an overview of our patent-protected assets and research tools currently available for partnering, please see our respective portfolio below:

Therapeutics
Discovery and development of innovative small molecules, biologics, vaccines, immune and cell therapies for an effective prevention and treatment of diseases with high unmet medical need.

Diagnostics & Medical Devices
Discovery and development of novel biomarkers, diagnostic antibodies, probes, imaging tools and medical devices supporting precision diagnostics and personalized medicine.